baber/WOPTO huggingface dataset:
Patent AU-2368200-A (AU)
Title: Exo-r-mecamylamine formulation and use in treatment
Inventor: SHYTLE DOUGLAS
IPC: C07C211/34
Filed: 1999-12-16
Abstract: A pharmaceutical composition includes a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of exo-R-mecamylamine in combination with a pharmaceutically acceptable carrier. Preferably the amount is about 0.5 mg to about 20 mg. Medical conditions are treated by administering a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of its exo-R-mecamylamine, said amount being sufficient to ameliorate the medical condition. The medical conditions include but are not limited to substance addiction (involving nicotine, cocaine, alcohol, amphetamine, opiate, other psychostimulant and a combination thereof), aiding smoking cessation, treating weight gain associated with smoking cessation, hypertension, hypertensive crisis, Tourette's Syndrome and other tremors, cancer (such as small cell lung cancer), atherogenic profile, neuropsychiatric disorders (such as bipolar disorder, depression, an anxiety disorder, schizophrenia, a seizure disorder, Parkinson's disease and attention deficit hyperactivity disorder), chronic fatigue syndrome, Crohn's disease, autonomic dysreflexia, and spasmogenic intestinal disorders.
Patent AU-2519295-A (AU)
Title: Life-saving aid
Inventor: MCNAMEE JOHN BODEN
IPC: B63C9/00
Filed: 1995-05-29
Abstract: PCT No. PCT/AU95/00309 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed May 29, 1995 PCT Pub. No. WO95/32890 PCT Pub. Date Dec. 7, 1995A life-saving aid comprising an elongate inflatable tube provided with an automatic inflation device arranged to release CO2 gas to inflate the tube when immersed in water or manually triggered. When inflated, the tube forms an elongate substantially linear cylinder sufficiently rigid to at least support its own weight when held horizontally from a proximal end. The tube is compact when deflated, is throwable, has significant tensile strength, and is designed so that after inflation and use, gas may be readily excluded via oral inflation tube by releasing the valve and rolling the tube from distal end toward proximal end.
Patent AU-2817400-A (AU)
Title: Plasma-assisted processing of gaseous media
Inventor: INMAN MICHAEL
IPC: B01J15/00
Filed: 2000-02-28
Abstract: A reactor for the plasma-assisted processing of a gaseous medium, including a pair of electrodes having facing surfaces the separation of which is substantially uniform, with a body of dielectric material positioned between them and defining a plurality of gas passages extending through the space between the electrodes.
Patent AU-2842699-A (AU)
Title: Mobile push-rod key, safety barrel for said key and lock equipped with said barrel
Inventor: DARMANIN CHRISTIAN
IPC: E05B27/06
Filed: 1999-03-18
Abstract: The invention concerns a safety barrel (5) key (1), comprising a key body (3) with a through housing (31) substantially parallel to the key body (3) neutral plane, the housing (31) receiving a mobile push-rod (32), the push-rod (32) being designed to co-operate by one (36a) of its transverse ends, with a positioning member (133) outside the key and arranged perpendicular to the key channel (8) so as to move the push-rod (32) transversely, to push a mobile cylinder pin (218). The mobile push-rod (32) has lateral shaped parts (40, 41) and the key body (3) comprises on its flanks (30a, 30b) an orifice (34) emerging in the push-rod (32) housing. The push-rod (32) lateral shaped parts are designed to co-operate through said orifice (34) with a mobile cylinder pin (119).
Patent AU-2878197-A (AU)
Title: Method to manage an insulated cooling bed and relative insulated cooling bed
Inventor: BORDIGNON GIUSEPPE
IPC: B21B43/00
Filed: 1997-07-21
Abstract: Method to manage an insulated cooling bed placed downstream of at least one continuous casting machine with one or more feeder ways (12a, 12b, 12c, 12d) and upstream of an outlet rollerway (20) associated with a reheating and temperature-equalisation furnace (15) serving a rolling mill (16), the cooling bed (11) comprising at the inlet a first bridge crane transfer (21a) to load the billets (13) from the feeder ways (12a, 12b, 12c, 12d) and cooperating at the outlet with a bench (14) to collect the billets (13), wherein the first bridge crane transfer (21a) removes the billets (13) from one rollerway (12) or the other and lays them gradually onto the cooling bed (11) insulated at least at the lower part, a second bridge crane transfer (21b) removes the billets (13) from one or another rollerway (12) or from the cooling bed (11) and lays the billets (13) on the outlet rollerway (20) or on the collection bench (14), the billets (13) being made to advance on the cooling bed (11) rotating on their axis. Cooling bed placed between at least a continuous casting machine and a rolling mill (16), including upstream one or more feeder rollerways (12) and downstream an outlet rollerway (20) associated with a bench (14) to collect cold billets and with a reheating and temperature-equalisation furnace (15), the bed comprising positioning seatings (19) for the billets (13) and a first bridge crane transfer (21a), the cooling bed (11) including at least at the lower part an insulated containing structure (18) and comprising a second bridge crane transfer (21b) which is driven autonomously and independently in relation to the first bridge crane transfer (21a), the second bridge crane transfer (21b) being functionally associated at least with the feeder rollerways (12), the positioning seatings (19) for the billets (13) and the outlet rollerway (20). <IMAGE>
Patent AU-3009284-A (AU)
Title: Piperazino substituted pteridines
Inventor: ROCH JOSEF
IPC: A61K31/505
Filed: 1984-07-02
Abstract: New 2-piperazino-pteridines of general formula   <IMAGE>  are described  wherein R1 represents a phenylalkylamino, alkylamino or dialkylamino group, a piperidino, morpholino, thiomorpholino, or 1-oxidothiomorpholino group, R2 represents a dialkylamino, piperidino, morpholino, thiomorpholino or 1-oxidothiomorpholino group and R3 represents a halogen atom, an alkoxy, alkylthio, phenylalkoxy or phenylalkylthio group, wherein the alkyl moiety may contain from 1 to 3 carbon atoms, and the acid addition salts thereof, particularly the physiologically acceptable acid addition salts thereof which have valuable pharmacological properties, particularly antithrombotic and metastasis-inhibiting effects. Processes for preparing the compounds of formula (I) are also described.
Patent AU-3614099-A (AU)
Title: Bone implant
Inventor: REVELL PETER ALLEN
IPC: A61L27/30
Filed: 1999-04-16
Abstract: A bone implant having a surface comprising a bioactive material, said bioactive material having incorporated therein ions from one or more of the groups of the periodic table consisting of groups IIA, IVA, VIIA and transition elements, said bioactive material being a material that is capable of promoting bone growth onto the bone implant.
Patent AU-3694495-A (AU)
Title: Enhanced ophthalmic lens
Inventor: EDWARDS SIMON JOHN
IPC: G02C7/06
Filed: 1995-10-20
Abstract: PCT No. PCT/AU95/00695 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Oct. 20, 1995 PCT Pub. No. WO96/12984 PCT Pub. Date May 2, 1996A progressive ophthalmic lens including a lens surface having: a lower viewing zone providing good optical quality at a predetermined high surface power over a large area of vision; said predetermined power being determined by the viewer's near prescription (Rx) the horizontal fitting position normally being determined by the near pupillary distance of the wearer, and the vertical fitting position normally being determined by the vertical frame midpoint, an upper viewing zone of lower surface power providing an enhanced range of vision for intermediate or greater viewing distances; and a corridor of relatively low astigmatism extending therebetween; wherein the contours of mean surface power and/or surface astigmatism within the lower viewing zone, upper viewing zone and corridor are generally symmetric about a vertical lens meridian as fitted to the wearer.
Patent AU-3905989-A (AU)
Title: Substituted 2,6-substituted 1,2-or 1,6-dihydro pyridine compounds
Inventor: CHUPP JOHN PAUL
IPC: C07D401/06
Filed: 1989-07-28
Abstract: Compounds of general formula <CHEM>  wherein:  one of Y1 and Y2 is <CHEM>  in which Z1 is selected from -SR, -OR, <CHEM> where R, R4 and R5 are the same or different and are selected from alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, and cyanoalkyl, and <CHEM> is selected from azetidinyl and a saturated or unsaturated 5-membered heterocyclic ring moiety containing 1-2 nitrogen atoms, the remaining atoms being carbon atoms, optionally substituted with 1 to 3 groups which are the same or different and are selected from alkyl, alkoxy, cyano, halo, nitro, haloalkyl, alkoxyalkyl, and dialkoxyalkyl; Z2 is selected from O and S;  the other of Y1 and Y2 is <CHEM>  where <CHEM>  is as defined above; R1 and R2 are independently selected from fluorinated methyl, chlorofluorinated methyl, chlorinated methyl, and lower alkyl radicals, provided that one of R1 and R2 must be a fluorinated methyl or chlorofluorinated methyl radical; X is selected from lower alkyl, cycloalkylalkyl, alkoxyalkyl and alkylthioalkyl, useful as halicids.
Patent AU-3906895-A (AU)
Title: DNA amplification fingerprinting
Inventor: BASSAM BRANT J
IPC: C12N15/09
Filed: 1995-11-24
Abstract: A method for amplifying nucleic acid sequences in a template comprising at least one nucleic acid or mixture of nucleic acids wherein each nucleic acid comprises at least one strand. The method comprises the steps of treating the template with at least one oligonucleotide primer having a nucleic acid sequence that is substantially complementary to at least one nucleic acid sequence on the template under conditions such that the primer will bind to a segment that is substantially complementary to the primer, producing primed strands of nucleic acid. The primed strands produce extension strands, wherein the extension strands comprise the primer in combination with a sequence of nucleic acids that is substantially complementary to the template in a 5' to 3' direction from the primer. The extension strands are further treated with the primer producing amplification strands which are treated with primer. The amplification strands are repeatedly treated with primer to produce large numbers of amplification strands whereby the nucleic acid sequences of the amplification strands are substantially similar to nucleic acid sequences in the original template.
Patent AU-3924695-A (AU)
Title: A feeding device, in particular for pigs
Inventor: KASPERSEN PETER
IPC: A01K5/02
Filed: 1995-11-28
Abstract: PCT No. PCT/DK95/00479 Sec. 371 Date May 28, 1997 Sec. 102(e) Date May 28, 1997 PCT Filed Nov. 28, 1995 PCT Pub. No. WO96/16537 PCT Pub. Date Jun. 6, 1996A feeding device, in particular for pigs, of the kind comprising a feed container (10) with a tubular outlet and preferably connected to a tubular transporter, by means of which the feed is brought to the feeding device, and where the pigs may act on the lower part of the tube (10) with their snouts for delivery of the feed into a trough (4). The feeding device is particular in that the lower part of the tube (10) is shaped as a separate deflectably suspended part and where there is provided between this and the lower edge of the fixed part of the tube a portioning device, through which the feed is supplied when the deflectable part is deflected.
Patent AU-3926885-A (AU)
Title: Continuous bulk polymerization of acrylic monomers
Inventor: BRAND JULIA A
IPC: C08F2/02
Filed: 1985-02-28
Abstract: A process to continuously bulk polymerize acrylic monomers to prepare low molecular weight, uniform, polymers employs minor amounts of initiator and, optionally solvents, at short residence times and moderate reaction temperatures to provide high yields of a product suitable for high solids applications.
Patent AU-4021185-A (AU)
Title: A process for the preparation of 6-methyl-3,4-dihydro-1,2,3- oxathiazin-4-one 2,2-dioxide and its non-toxic salts
Inventor: CLAUSS KARL
IPC: C07D291/06
Filed: 1985-03-21
Abstract: 6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide is prepared by reaction of acetoacetamide with at least approximately twice the molar amount of SO3 per mole of acetoacetamide, if appropriate in an inert inorganic or organic solvent. Relevant salts can be obtained, using bases, from the product which results in the form of the acid. The non-toxic salts, in particular the potassium salt, are valuable synthetic sweeteners.
Patent AU-4159289-A (AU)
Title: Apparatus for separating solid particles from a fluid
Inventor: AKKER HENDRIKUS EGIDIUS ANTONI
IPC: B01D45/12
Filed: 1989-09-20
Abstract: Apparatus for separating solid particles from a fluid, comprising a swirl chamber (3) provided with a curved wall, a tangential inlet (9) and a solids outlet (13), both arranged perpendicular to the central longitudinal axis (5) of the swirl chamber (3). A swirl tube (16) extends coaxially into the swirl chamber (3) and has an open end (20) arranged in the swirl chamber (3) and a solids outlet opening (22) arranged outside the swirl chamber (3). A fluid outlet tube (28) has an outlet part (34) extending coaxially into the swirl chamber (3) in a direction opposite to the direction in which the swirl tube (16) extends and an inlet part (32) arranged in the swirl tube (16). Swirl imparting means (46) are arranged between the swirl tube (16) and the fluid outlet tube (28), so as to impart a swirl in the swirl tube (16), which swirl has the same direction of rotation as in the swirl chamber (3).
Patent AU-4263493-A (AU)
Title: Method for purifying an aqueous solution of raw albumin
Inventor: RUCHETON MARCEL
IPC: C07K14/765
Filed: 1993-04-22
Abstract: PCT No. PCT/FR93/00395 Sec. 371 Date Oct. 24, 1994 Sec. 102(e) Date Oct. 24, 1994 PCT Filed Apr. 22, 1993 PCT Pub. No. WO93/21228 PCT Pub. Date Oct. 28, 1993Method for purifying an aqueous solution of raw albumin wherein contaminant proteins are bound by chromatography to a stationary solid phase, preferably a particulate phase, the purified albumin solution being collected as an effluent, in which a neutral phase charged with at least one compound chosen from the group formed by compounds containing C3 to C8 alkyl radicals and compounds containing sulfate groups is used as the stationary phase.
Patent AU-4444801-A (AU)
Title: The production of dicalcium phosphate or monocalcium phosphate
Inventor: WAAL JAN CHRISTOFFEL DE
IPC: C01B25/32
Filed: 2001-04-04
Abstract: A process is provided for the production of dicalcium phosphate form a phosphate source material in which a solution of phosphoric acid is produced by the action of a suitable mineral acid, generally sulphuric acid, on a phosphate source material. Calcium fluoride is precipitated at a pH of between 3.5 and 4.5 followed by hydrolyzing the solution by diluting it with water to a ratio of approximately 1:7 to about 1:10 monocalcium phosphate to water at a temperature of approximately 40 degrees Centigrade to form a primary precipitate containing substantially all of the fluoride present as CaF<SUB>2 </SUB>together with some dicalcium phosphate and a primary calcium and phosphate containing solution. The primary precipitate is dissolved, the pH adjusted to form 3.5 to 4.5 and the hydrolyzation repeated to form a secondary precipitate containing substantially all of the fluoride present as CaF<SUB>2 </SUB>together with some dicalcium phosphate and a secondary calcium and phosphate containing solution. The secondary precipitate can optionally, if required, by again processed in the same way to recover more phosphates. The product dicalcium phosphate is recovered from the combined calcium and phosphate containing solutions.
Patent AU-4628189-A (AU)
Title: Light filter for improving vision
Inventor: MUTZHAS MAXIMILIAN FRIEDRICH
IPC: G02C7/10
Filed: 1989-11-07
Abstract: PCT No. PCT/EP89/01329 Sec. 371 Date Oct. 21, 1991 Sec. 102(e) Date Oct. 21, 1991 PCT Filed Nov. 7, 1989 PCT Pub. No. WO90/05321 PCT Pub. Date May 17, 1990.A light filter for filtering light for a human eye with the filter being formed of a plastic material in combination with the filtering material. The filtering material is added so as to provide the filter with spectral transmittance characteristics which include a cut-off location ( lambda H) of 450 nm to 550 nm, a steepness (S) for the transmittance curve at the cut-off location of at least 1%.nm-1, a means transmittance ( tau 2) in a spectral range from 380 to 450 nm of at most 20%, and a means transmittance ( tau 3) in a spectral range from 450 to 550 nm of at least 40%. The filtering material preferably includes an organic dye dissolved in the plastic or an organic pigment finely distributed in the plastic material. In addition, the mean transmittance ( tau 2) in the 380 to 450 nm spectral range is at most 10% and the means transmittance ( tau 3) in the 450 to 550 nm spectral range is at least 60%. Further, the light filter has a means transmittance of ( tau 4) in a 550 to 780 nm spectral range of at least 65% and a means transmittance ( tau 1) in a 250 to 380 nm spectral range of at most 10%.
Patent AU-4883900-A (AU)
Title: Universal ejection tool
Inventor: CHIARI MAURO
IPC: B26F1/40
Filed: 2000-07-26
Abstract: Ejection tool for cutting wastes comprises a frame (2) made of two identical plates (10,12) separated by lateral and transversal bars (3,4). There are separating band (17) placed between the plate to maintain their shape. The plates are bored at regular intervals, with the holes (11) of each plate facing each other. Pins (30) are passing two facing holes.
Patent AU-4893979-A (AU)
Title: Controlling parasites using 2-aryl-1,3-cyclohexanedione
Inventor: HAINES ROBERT GORDON
IPC: C07C49/657
Filed: 1979-07-16
Abstract: 2-Aryl-1,3-cyclohexanedione compounds and alkali metal salts, ammonium salts and enol esters thereof, composition and method of controlling acarina ectoparasites on warmblood animals. 
<??>There is disclosed a compound for use in controlling acarina ectoparasites on warmblood animals, which compound comprises a 2-aryl-1; 3-cyclohexanedione compound [e.g. 3-(2-Ethylhexanoyloxy)-5, 5-dimethyl-2-(2', 4'-dimethylphenyl)-2-cyclohexenone] of the formula 
<CHEM>
 the alkali metal salts, ammonium salts and enol ester derivative thereof are also disclosed. 
<??>There is also disclosed a composition comprising a compound of the invention together with a carrier, and a method of controlling acarina ectoparasites on warmblooded animals by orally administering to the animals an ectoparasitically effective amount of a compound or a composition of the invention; several methods for preparing of this compounds, salts and esters are given.
Patent AU-4960785-A (AU)
Title: A positionable tissue interfacing device for the management of percutaneous conduits
Inventor: KENICHI YAMAMOTO RONALD
IPC: A61M25/02
Filed: 1985-09-20
Abstract: This invention is a sleeve-like tissue-interface device designed to reduce the incidence of nosocomial infection related to percutaneous conduits by promoting a tissue seal where the conduit and skin interface, and by the expression of antibacterial activity to reduce the possibility of bacteria advancing along the conduit into deeper tissues. In particular, the positionability of the invention allows it to be placed onto a catheter-like device, in the dermal and subcutaneous tissue below the catheter exit site, although this position relative to catheter length is variable at different anatomical sites, and from patient to patient. The positionability feature also allows the invention to be used in conjunction with existing percutaneous access devices such as catheters and wound drains, as an optional measure against bacterial infection.
Patent AU-5024999-A (AU)
Title: High-voltage semiconductor component, method for the production and use thereof
Inventor: SILBER DIETER
IPC: H01L21/762
Filed: 1999-05-10
Abstract: The invention concerns a semiconductor component with at east one lateral region which is provided to accommodate a lateral electric field strength, whereby the semiconductor body within the body and/or in regions proximal to the surface of the semiconductor body at least over regions thereof has a lateral three-dimensional structure which has vertical recesses in the semiconductor body within which there are electrical conductors which are smaller than in the intervening spaces of the semiconductor body between the recesses, as well as a method for making and of using the semiconductor component.
Patent AU-5053293-A (AU)
Title: Method of controlling an automated mechanical transmission shift mechanism
Inventor: JANECKE DANIEL PAUL
IPC: F16H61/02
Filed: 1993-11-08
Abstract: For use with an automated mechanical transmission system including an electrically actuated shift mechanism (12) having a motor (70, 72), a method of controlling the shift mechanism is provided for shifting the transmission (10) out of gear during a reduced torque shift window by quickly detecting motor motion. The shift mechanism is first energized with a low effective voltage signal (100) to minimize power consumption and avoid overheating the motor, and then with a high effective voltage signal (106) upon detection of motor motion (104), to quickly shift the transmission (10) out of gear. <IMAGE>
Patent AU-5094285-A (AU)
Title: Variable stroke free piston engine
Inventor: BRAUN ANTON
IPC: F01B11/02
Filed: 1985-10-10
Abstract: A free piston engine includes speed control means which provide a wide range of engine speed control for selective connection and use of the engine with any one of a number of different types of energy absorbing devices. The desired control is achieved by use of two bounce chambers (18p and 18n) and a double-acting bounce piston unit (16) specifically located at an intermediate position along the axis of reciprocation of the piston rod assembly of such an engine, i.e. between a power piston (15) at one end of the piston rod and a connecting means at the other piston rod end for driving connection of the piston rod assembly with a movable member (e.g. reciprocating compressor piston (34) or reciprocating electric generator member) of the selected energy absorbing device. The control means further includes at least one pair of variably adjustable bounce chamber pressure control valves (23 and 24), one for each bounce chamber. Each control valve of such one pair provides for and controls a direct connection of its respective bounce chamber to ambient atmospheric air outside the bounce chamber. The controls further include sensing means (37) responsive to changes in demands on or operation of the selected energy absorbing device for variably and substantially simultaneously adjusting each control valve of such one pair and thereby similarly changing (i.e. both upwardly or both downwardly) the respective bounce chamber working pressures. Other bounce pressure control features are also described.